(NASDAQ:IRD), Pediatric participants demonstrated large gains in cone-mediated vision; therapy remains well tolerated with no ocular serious adverse events or dose-limiting toxicities Lasting, durable responses observed out to 18 months in adult participants Expected FDA Meeting in Q4 2025 Management to Host Webcast and Conference Call Today at 8:30 A.M. ET RESEARCH TRIANGLE PARK, N.C., […]

(NASDAQ:TROW), New York, New York, Sept. 30, 2025 (GLOBE NEWSWIRE) — Oak Hill Advisors (“OHA”) served as Administrative Agent and Lead Left Arranger for a private unitranche financing supporting Francisco Partners' acquisition of Elite. Elite is a leading provider of mission-critical enterprise resource planning (“ERP”) software and integrated payment solutions for law firms globally. OHA

Based on previously reported positive Phase 1 results, Kynexis is advancing KYN-5356, a first-in-class KAT-II inhibitor, into a Phase 2 clinical trial in patients with cognitive impairment associated with schizophrenia Phase 2 trial seeks to establish proof-of-concept of KYN-5356; topline results are expected by Q4 2026 NAARDEN, The Netherlands, Sept. 30, 2025 (GLOBE NEWSWIRE) —

BELLEVUE Wash., Sept. 30, 2025 (GLOBE NEWSWIRE) — Louisiana State University (LSU) has deployed ManageX Research, a self-service cloud platform from Terawe, to empower its researchers with instant access to advanced cloud infrastructure and AI services. The platform enables LSU's faculty and students to launch high-performance computing environments within minutes–dramatically reducing the time and effort

(NasdaqGM:EDAP), Focal One(R) Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option Focal One Robotic HIFU Patient Story Featured on Health Uncensored with Dr. Drew on Lifetime Network AUSTIN, Texas – September 30, 2025 – EDAP TMS SA (Nasdaq: EDAP), a global leader in robotic energy-based therapies, announced that its non-invasive, nonsurgical

LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025 GlobeNewswire September 30, 2025 Additional time enables LAVA Therapeutics to address potential liabilities and confirm net cash to be delivered to Shareholders. LAVA Therapeutics and XOMA Royalty anticipate closing the announced acquisition in the fourth quarter of 2025. UTRECHT, The Netherlands and PHILADELPHIA, Sept.

Anfield Provides Positive Update Regarding its Confirmation Drill Program at Its JD-7 Mine GlobeNewswire September 30, 2025 VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) — Anfield Energy Inc. (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce the completion of the first 12 holes of the Company's ongoing 20-hole,

Wrap Technologies, Inc. Plans to Hold a Conference Call to Discuss Third Quarter 2025 Financial Results on Wednesday, November 12, 2025, at 4:30 p.m. ET GlobeNewswire September 30, 2025 MIAMI, Sept. 30, 2025 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in innovative public safety technologies and non-lethal

Green Thumb Expands Pennsylvania Retail Footprint with RISE Dispensary Lebanon GlobeNewswire September 30, 2025 Conveniently located near Downtown Lebanon off Route 422, RISE Dispensary Lebanon is located at 1600 W Cumberland St. Lebanon, PA 17042. RISE Dispensary Lebanon will host a grand opening celebration for its patients and the community on October 3. Continuing with

Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings GlobeNewswire September 30, 2025 NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) — Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and